Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors

author
created [InstanceEdit:9680582] Rothfels, Karen, 2020-03-27
dbId 9680576
displayName Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors
journal Clin. Cancer Res.
pages 7287-7293
pubMedIdentifier 31471313
schemaClass LiteratureReference
title Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors
url http://www.ncbi.nlm.nih.gov/pubmed/31471313
volume 25
year 2019
Cite Us!